全文获取类型
收费全文 | 38339篇 |
免费 | 1948篇 |
国内免费 | 253篇 |
专业分类
耳鼻咽喉 | 374篇 |
儿科学 | 774篇 |
妇产科学 | 683篇 |
基础医学 | 4355篇 |
口腔科学 | 1321篇 |
临床医学 | 3066篇 |
内科学 | 9826篇 |
皮肤病学 | 718篇 |
神经病学 | 4043篇 |
特种医学 | 1051篇 |
外科学 | 5930篇 |
综合类 | 111篇 |
一般理论 | 11篇 |
预防医学 | 1929篇 |
眼科学 | 704篇 |
药学 | 2194篇 |
中国医学 | 78篇 |
肿瘤学 | 3372篇 |
出版年
2024年 | 27篇 |
2023年 | 271篇 |
2022年 | 527篇 |
2021年 | 1226篇 |
2020年 | 716篇 |
2019年 | 988篇 |
2018年 | 1132篇 |
2017年 | 869篇 |
2016年 | 937篇 |
2015年 | 1072篇 |
2014年 | 1569篇 |
2013年 | 1955篇 |
2012年 | 3118篇 |
2011年 | 3098篇 |
2010年 | 1774篇 |
2009年 | 1622篇 |
2008年 | 2652篇 |
2007年 | 2677篇 |
2006年 | 2450篇 |
2005年 | 2394篇 |
2004年 | 2265篇 |
2003年 | 1889篇 |
2002年 | 1841篇 |
2001年 | 260篇 |
2000年 | 174篇 |
1999年 | 220篇 |
1998年 | 356篇 |
1997年 | 277篇 |
1996年 | 255篇 |
1995年 | 224篇 |
1994年 | 175篇 |
1993年 | 171篇 |
1992年 | 140篇 |
1991年 | 115篇 |
1990年 | 102篇 |
1989年 | 80篇 |
1988年 | 78篇 |
1987年 | 82篇 |
1986年 | 82篇 |
1985年 | 73篇 |
1984年 | 93篇 |
1983年 | 53篇 |
1982年 | 54篇 |
1981年 | 60篇 |
1980年 | 51篇 |
1979年 | 32篇 |
1978年 | 22篇 |
1977年 | 40篇 |
1975年 | 23篇 |
1974年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Cost‐Effectiveness and Cost‐Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study
下载免费PDF全文
![点击此处可从《Neuromodulation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Furio Zucco MD Roberta Ciampichini MSc Angelo Lavano MD Amedeo Costantini MD Marisa De Rose MD Paolo Poli MD Gianpaolo Fortini MD Laura Demartini MD Enrico De Simone MD Valentino Menardo MD Piero Cisotto MD Mario Meglio MD Luciana Scalone PhD Lorenzo G. Mantovani DSc 《Neuromodulation》2015,18(4):266-276
5.
6.
Alessia Scarselli Silvia Di Cesare Claudia Capponi Simona Cascioli Maria L. Romiti Gigliola Di Matteo Alessandra Simonetti Paolo Palma Andrea Finocchi Barbarella Lucarelli Rita M. Pinto Ippolita Rana Giuseppe Palumbo Maurizio Caniglia Paolo Rossi Rita Carsetti Caterina Cancrini Alessandro Aiuti 《Journal of clinical immunology》2015,35(4):373-383
7.
Enrique Luengo Izaskun Buendia Cristina Fernndez‐Mendívil Paula Trigo‐Alonso Pilar Negredo Patrycja Michalska Borja Hernndez‐García Cristina Snchez‐Ramos Juan A. Bernal Tsuneya Ikezu Rafael Len Manuela G. Lpez 《Journal of pineal research》2019,67(1)
Alterations in autophagy are increasingly being recognized in the pathogenesis of proteinopathies like Alzheimer's disease (AD). This study was conducted to evaluate whether melatonin treatment could provide beneficial effects in an Alzheimer model related to tauopathy by improving the autophagic flux and, thereby, prevent cognitive decline. The injection of AAV‐hTauP301L viral vectors and treatment/injection with okadaic acid were used to achieve mouse and human ex vivo, and in vivo tau‐related models. Melatonin (10 μmol/L) impeded oxidative stress, tau hyperphosphorylation, and cell death by restoring autophagy flux in the ex vivo models. In the in vivo studies, intracerebroventricular injection of AAV‐hTauP301L increased oxidative stress, neuroinflammation, and tau hyperphosphorylation in the hippocampus 7 days after the injection, without inducing cognitive impairment; however, when animals were maintained for 28 days, cognitive decline was apparent. Interestingly, late melatonin treatment (10 mg/kg), starting once the alterations mentioned above were established (from day 7 to day 28), reduced oxidative stress, neuroinflammation, tau hyperphosphorylation, and caspase‐3 activation; these observations correlated with restoration of the autophagy flux and memory improvement. This study highlights the importance of autophagic dysregulation in tauopathy and how administration of pharmacological doses of melatonin, once tauopathy is initiated, can restore the autophagy flux, reduce proteinopathy, and prevent cognitive decline. We therefore propose exogenous melatonin supplementation or the development of melatonin derivatives to improve autophagy flux for the treatment of proteinopathies like AD. 相似文献
8.
9.
Willy Baccaglini Felipe A. Glina Cristiano Linck Pazeto Luis G. Medina Fernando Korkes Wanderley M. Bernardo Rene Sotelo Sidney Glina Giancarlo Marra Marco Moschini Xavier Cathelineau Rafael Sanchez-Salas 《Clinical genitourinary cancer》2021,19(1):3-11.e1
This meta-analysis focuses on the accuracy of upgrading to clinically significant prostate cancer (PCa) by multiparametric magnetic resonance imaging-targeted biopsy (MRI-TB) versus systematic biopsy (SB). We searched the Medline, Embase, Cochrane Central Register of Controlled Trials, Web of Science, Scopus, and Literatura Latino Americana em Ciências da Saúde databases through January 2020 for comparative, retrospective/prospective, paired-cohort, and randomized clinical trials with paired comparisons. The population consisted of patients with low-risk PCa in active surveillance with at least 1 index lesion on imaging. We evaluated the quality of evidence by using the Quality Assessment of Diagnostic Accuracy Studies-2 score. Group comparisons considered the differences between the area under the curve summary receiver operating characteristic curve in a 2-tailed method. We also compared the positive predictive value of the best single method (MRI-TB or SB) and the referral study test (combined biopsy, a combination of MRI-TB and SB). The meta-analysis included 6 studies enrolling 741 patients. The pooled sensitivity for the 2 groups was 0.79 (95% confidence interval, 0.74-0.83; I2 = 75%) and 0.67 (95% confidence interval, 0.63-0.74; I2 = 55.4%), respectively. The area under the curve for the MRI-TB and SB groups were 0.99 and 0.92 (P < .001), respectively. The positive predictive value for the MRI-TB and combined biopsy groups were similar. The accumulated evidence suggests better results for MRI-TB compared with SB. Therefore, use of MRI-TB alone may be preferable in patients in active surveillance harboring low-risk PCa. 相似文献
10.